《星際戰甲》國服獲得版號 創夢天地(1119.HK)負責運營工作
格隆匯11月9日丨國家新聞出版署11月5日對“2020年進口網絡遊戲審批信息”進行了更新,客户端遊戲《星際戰甲》確認過審獲得版號。據新聞出版署官網信息顯示,《星際戰甲》國服由深圳市創夢天地科技有限公司出版並運營,創夢天地是一家大型獨立手遊發行平台,以發行海外精品手遊著稱,先後成功發行了《水果忍者》、《神廟逃亡》系列、《地鐵跑酷》、《紀念碑谷》、《夢幻花園》等眾多全球知名休閒手遊。《星際戰甲》是一款在不斷變化的科幻世界中的多人合作免費在線動作遊戲。和你的同伴一起加入遍佈太陽系的玩家與敵人對抗遊戲,駕馭 Warframe 。單獨作戰或者一起對抗威脅整個世界的敵人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.